Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 27 | 2020 | 3475 | 2.040 |
Why?
|
| Contrast Media | 15 | 2020 | 1084 | 1.590 |
Why?
|
| Carcinogenesis | 3 | 2020 | 214 | 1.140 |
Why?
|
| Vanadates | 8 | 2009 | 32 | 1.100 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 168 | 1.070 |
Why?
|
| Vanadium | 3 | 2015 | 13 | 0.940 |
Why?
|
| Gadolinium DTPA | 7 | 2017 | 256 | 0.880 |
Why?
|
| Electron Spin Resonance Spectroscopy | 15 | 2005 | 318 | 0.850 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2020 | 57 | 0.850 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 119 | 0.800 |
Why?
|
| beta-Lactamases | 5 | 2004 | 56 | 0.670 |
Why?
|
| Arteries | 1 | 2020 | 179 | 0.660 |
Why?
|
| Spin Labels | 8 | 2013 | 106 | 0.650 |
Why?
|
| Mammary Glands, Animal | 5 | 2020 | 80 | 0.600 |
Why?
|
| Calcium Oxalate | 2 | 2015 | 186 | 0.590 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 275 | 0.590 |
Why?
|
| Feeding Behavior | 1 | 2020 | 328 | 0.580 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 127 | 0.580 |
Why?
|
| Microscopy, Fluorescence | 3 | 2015 | 434 | 0.560 |
Why?
|
| Dietary Fats | 1 | 2017 | 135 | 0.540 |
Why?
|
| Durapatite | 1 | 2015 | 31 | 0.510 |
Why?
|
| Prostate | 2 | 2017 | 407 | 0.500 |
Why?
|
| Poloxamer | 3 | 2017 | 29 | 0.490 |
Why?
|
| Electron Probe Microanalysis | 1 | 2015 | 8 | 0.490 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 2393 | 0.490 |
Why?
|
| Animals | 33 | 2020 | 27528 | 0.430 |
Why?
|
| Mice | 17 | 2020 | 11851 | 0.430 |
Why?
|
| Surface-Active Agents | 2 | 2017 | 61 | 0.420 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 462 | 0.420 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 80 | 0.410 |
Why?
|
| Glycoproteins | 3 | 2000 | 235 | 0.400 |
Why?
|
| Models, Molecular | 9 | 2005 | 1315 | 0.380 |
Why?
|
| Colitis | 2 | 2014 | 247 | 0.380 |
Why?
|
| Organometallic Compounds | 3 | 2013 | 137 | 0.350 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 603 | 0.320 |
Why?
|
| Tumor Burden | 2 | 2020 | 310 | 0.290 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 569 | 0.290 |
Why?
|
| Prostatic Hyperplasia | 2 | 2019 | 90 | 0.280 |
Why?
|
| Muramidase | 3 | 2017 | 35 | 0.280 |
Why?
|
| Escherichia coli | 5 | 2004 | 607 | 0.270 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 571 | 0.270 |
Why?
|
| Binding Sites | 9 | 2004 | 1121 | 0.260 |
Why?
|
| Calcium | 4 | 2002 | 1179 | 0.250 |
Why?
|
| Molecular Structure | 6 | 2007 | 293 | 0.230 |
Why?
|
| Protein Conformation | 7 | 2004 | 895 | 0.230 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2015 | 117 | 0.230 |
Why?
|
| Cations, Divalent | 1 | 2003 | 39 | 0.220 |
Why?
|
| Pyrophosphatases | 1 | 2003 | 16 | 0.220 |
Why?
|
| Ions | 2 | 2000 | 75 | 0.210 |
Why?
|
| Gadolinium | 3 | 2015 | 103 | 0.210 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 397 | 0.210 |
Why?
|
| Kinetics | 7 | 2004 | 1534 | 0.200 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1744 | 0.200 |
Why?
|
| Rats | 8 | 2013 | 4048 | 0.200 |
Why?
|
| Methyl Methanesulfonate | 1 | 2002 | 4 | 0.200 |
Why?
|
| Carboxypeptidases | 2 | 1994 | 35 | 0.200 |
Why?
|
| Neoplasms | 4 | 2020 | 3065 | 0.190 |
Why?
|
| Female | 14 | 2020 | 46595 | 0.180 |
Why?
|
| Polyethylene Glycols | 2 | 2017 | 360 | 0.180 |
Why?
|
| Cyclic N-Oxides | 3 | 1993 | 33 | 0.180 |
Why?
|
| Glutamic Acid | 1 | 2001 | 154 | 0.180 |
Why?
|
| Cattle | 4 | 2007 | 378 | 0.180 |
Why?
|
| Water | 4 | 2008 | 286 | 0.170 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 198 | 0.170 |
Why?
|
| Organ Size | 1 | 2020 | 372 | 0.170 |
Why?
|
| Dietary Sugars | 1 | 2018 | 8 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 2587 | 0.150 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 12 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3252 | 0.150 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 31 | 0.150 |
Why?
|
| Injections, Intravenous | 2 | 2015 | 238 | 0.150 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1576 | 0.150 |
Why?
|
| Ligands | 3 | 2016 | 447 | 0.150 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2017 | 21 | 0.150 |
Why?
|
| Weaning | 1 | 2017 | 25 | 0.140 |
Why?
|
| Catalysis | 5 | 2003 | 205 | 0.140 |
Why?
|
| Ethylenediamines | 1 | 2017 | 14 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2018 | 134 | 0.140 |
Why?
|
| Protein Unfolding | 1 | 2017 | 13 | 0.140 |
Why?
|
| Protein Aggregates | 1 | 2017 | 24 | 0.140 |
Why?
|
| Adiposity | 1 | 2017 | 76 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 696 | 0.140 |
Why?
|
| ADAM17 Protein | 1 | 2016 | 9 | 0.140 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 16 | 0.140 |
Why?
|
| Protein Denaturation | 2 | 2007 | 106 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 45 | 0.130 |
Why?
|
| Simian virus 40 | 1 | 2015 | 35 | 0.130 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2015 | 47 | 0.130 |
Why?
|
| Carboxypeptidases A | 3 | 2007 | 11 | 0.120 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 52 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2014 | 1255 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 471 | 0.120 |
Why?
|
| ErbB Receptors | 2 | 2016 | 499 | 0.120 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 33 | 0.120 |
Why?
|
| Epithelium | 1 | 2015 | 323 | 0.120 |
Why?
|
| Models, Animal | 1 | 2015 | 277 | 0.120 |
Why?
|
| Glycolysis | 1 | 2015 | 135 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 81 | 0.110 |
Why?
|
| Image Enhancement | 3 | 2020 | 565 | 0.110 |
Why?
|
| Diffusion | 1 | 2013 | 93 | 0.110 |
Why?
|
| Artifacts | 1 | 2015 | 246 | 0.110 |
Why?
|
| Acylation | 3 | 2004 | 40 | 0.110 |
Why?
|
| Circular Dichroism | 3 | 2000 | 117 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 130 | 0.110 |
Why?
|
| Radiography | 1 | 2015 | 808 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 160 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 3 | 2012 | 354 | 0.110 |
Why?
|
| Penicillanic Acid | 2 | 2004 | 11 | 0.110 |
Why?
|
| Freezing | 2 | 2004 | 33 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 61 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1237 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 338 | 0.100 |
Why?
|
| Solutions | 3 | 2005 | 86 | 0.100 |
Why?
|
| Hydrolysis | 2 | 2004 | 141 | 0.100 |
Why?
|
| Niacinamide | 1 | 2012 | 98 | 0.100 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 95 | 0.100 |
Why?
|
| Microvessels | 2 | 2009 | 69 | 0.100 |
Why?
|
| Male | 8 | 2019 | 42682 | 0.100 |
Why?
|
| Solvents | 2 | 2002 | 97 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2011 | 816 | 0.090 |
Why?
|
| Deuterium | 2 | 2001 | 33 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2011 | 94 | 0.090 |
Why?
|
| Molecular Conformation | 3 | 2005 | 96 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 91 | 0.090 |
Why?
|
| Intestines | 1 | 2013 | 416 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 293 | 0.090 |
Why?
|
| Camellia sinensis | 1 | 2009 | 7 | 0.080 |
Why?
|
| Angiogenesis Modulating Agents | 1 | 2009 | 4 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2010 | 338 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 128 | 0.080 |
Why?
|
| Protein Structure, Secondary | 2 | 2017 | 333 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 586 | 0.080 |
Why?
|
| Humans | 12 | 2019 | 89970 | 0.080 |
Why?
|
| Protons | 3 | 2008 | 101 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 45 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 784 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2009 | 245 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 95 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 105 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 2018 | 0.070 |
Why?
|
| Progesterone | 1 | 2007 | 110 | 0.070 |
Why?
|
| Drug Design | 1 | 2007 | 126 | 0.070 |
Why?
|
| Algorithms | 3 | 2010 | 1913 | 0.070 |
Why?
|
| Protein Binding | 3 | 2002 | 1491 | 0.070 |
Why?
|
| Substrate Specificity | 3 | 2004 | 352 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 3048 | 0.070 |
Why?
|
| Protein Renaturation | 1 | 2005 | 4 | 0.070 |
Why?
|
| Injections | 2 | 2017 | 116 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 54 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1801 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2005 | 102 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2005 | 69 | 0.060 |
Why?
|
| Models, Biological | 2 | 2009 | 1766 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2004 | 417 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2767 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 3022 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 26 | 0.060 |
Why?
|
| Enterobacter cloacae | 1 | 2004 | 8 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 980 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 38 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 491 | 0.060 |
Why?
|
| Manganese | 1 | 2003 | 55 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 503 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 351 | 0.050 |
Why?
|
| Magnesium | 1 | 2003 | 178 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 594 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 677 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2009 | 764 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 121 | 0.050 |
Why?
|
| Chickens | 2 | 2017 | 212 | 0.050 |
Why?
|
| Surface Properties | 1 | 2002 | 131 | 0.050 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2001 | 3 | 0.050 |
Why?
|
| Penicillin G | 1 | 2001 | 4 | 0.050 |
Why?
|
| Asparagine | 1 | 2001 | 30 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 137 | 0.050 |
Why?
|
| Vanadium Compounds | 1 | 2000 | 2 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 463 | 0.050 |
Why?
|
| Malonates | 1 | 2000 | 11 | 0.050 |
Why?
|
| Magnetics | 1 | 2000 | 41 | 0.050 |
Why?
|
| Anisotropy | 1 | 2000 | 63 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 283 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 371 | 0.040 |
Why?
|
| beta-Lactams | 1 | 2000 | 14 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2015 | 0.040 |
Why?
|
| Nitrogen | 1 | 2000 | 73 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 278 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 195 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 511 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2064 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3024 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 493 | 0.040 |
Why?
|
| Fructose | 1 | 2018 | 36 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 644 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 327 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 300 | 0.030 |
Why?
|
| Estradiol | 1 | 2017 | 250 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 50 | 0.030 |
Why?
|
| Spiro Compounds | 1 | 2016 | 26 | 0.030 |
Why?
|
| Diet, Western | 1 | 2016 | 38 | 0.030 |
Why?
|
| Metals | 1 | 1996 | 93 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 996 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2019 | 473 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 468 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1148 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 1994 | 740 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 163 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 292 | 0.030 |
Why?
|
| Cations | 1 | 1995 | 30 | 0.030 |
Why?
|
| Porphyrins | 1 | 1995 | 39 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1607 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2014 | 47 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3404 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 93 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 28 | 0.030 |
Why?
|
| Succinates | 1 | 1994 | 21 | 0.030 |
Why?
|
| Amino Acids | 1 | 1995 | 246 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 109 | 0.030 |
Why?
|
| Oxyquinoline | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2013 | 14 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 25 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.030 |
Why?
|
| Mammography | 1 | 2017 | 475 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2013 | 73 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 165 | 0.030 |
Why?
|
| Kidney Calculi | 1 | 1996 | 343 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1993 | 15 | 0.030 |
Why?
|
| Perfusion | 1 | 2014 | 253 | 0.030 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1993 | 42 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 449 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 485 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2019 | 9210 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2015 | 550 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 46 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 368 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 582 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 103 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 295 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 649 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 96 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 208 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1469 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 786 | 0.020 |
Why?
|
| Extremities | 1 | 2011 | 174 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2002 | 1008 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 662 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 92 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1309 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2008 | 108 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2008 | 52 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1669 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2008 | 128 | 0.020 |
Why?
|
| Liver | 1 | 1993 | 1211 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 19254 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 785 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 872 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 175 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1665 | 0.020 |
Why?
|
| Pyrones | 1 | 2005 | 8 | 0.020 |
Why?
|
| Glycogen Synthase | 1 | 2005 | 22 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2005 | 34 | 0.020 |
Why?
|
| Electroporation | 1 | 2005 | 57 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 26148 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 26822 | 0.020 |
Why?
|
| Tyrosine | 1 | 2005 | 133 | 0.020 |
Why?
|
| Glycogen | 1 | 2005 | 59 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 576 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 1102 | 0.010 |
Why?
|
| Adipocytes | 1 | 2005 | 163 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 696 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 353 | 0.010 |
Why?
|
| Amino Acids, Acidic | 1 | 2002 | 1 | 0.010 |
Why?
|
| Lithostathine | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dialysis | 1 | 2002 | 24 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 1130 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 146 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 338 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2000 | 10 | 0.010 |
Why?
|
| Culture Media | 1 | 2000 | 147 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 5359 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 90 | 0.010 |
Why?
|
| Tryptophan | 1 | 1994 | 97 | 0.010 |
Why?
|
| Alcohols | 1 | 1993 | 15 | 0.010 |
Why?
|
| Horses | 1 | 1993 | 35 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1994 | 188 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1993 | 60 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 4168 | 0.000 |
Why?
|